Skip directly to content

FAQs

The Healthcare Hub Competitive Grants Process 2017 is now closed for applications. Please see below to find out what's next.
What is Pfizer looking for?
  • Clearly defined market need – however you define your market
  • Innovative solutions that support: Self-care, health awareness, monitoring and information, earlier detection and better diagnostics, treatment optimisation – pathway improvement, data-enabled decision-making, improved communication for care, social and psychological support
  • Patient Impact: Even if the impact comes indirectly through improving NHS or providers workflow
  • Proven technology: A CE mark (if required), and some real world data from a pilot, a beta or evidence from early adoption of the innovation.
  • Feasibility: Pfizer works in the real world and we also expect you to do so too. Knowing your value and keeping your solution as simple as it needs to be but no more, is critical. You need to understand the challenges across the UK health economy and need to have identified what it is that you require in order to grow.
  • Scalability: Variations in care are a real challenge for patients and funders in the developed and developing economies. We are looking for companies with the potential to scale.
Who can apply to the CGP process?

Any legal entity who possesses the attributes we are looking for may apply. All applications are required to be submitted through this online portal only.

Will Pfizer take any equity or claim ownership of any intellectual rights to the technology?

Pfizer has no commercial interest in the applicants’ business and will not take any equity or have claims on the IP. 

What happens after the submission?

The Pfizer Healthcare Hub: London team will review all the applications and contact you by 5th May 2017 if you are shortlisted for the pitch event.

Shortlisted companies will be asked to support any claims made such as CE marking etc.

Up to 10 shortlisted companies will be invited to submit short elevator videos by 10th May for the Hub to share internally with our 2,000+ UK colleagues and beyond to help you generate as much support for your application as possible from every corner of our business.

Shortlisted companies will be invited to attend a live pitch and assessment day on 18th May at Pfizer UK headquarters, Walton Oaks, Surrey.

As a leading biopharmaceutical company we take our commitments to the public, patients and providers seriously and shortlisted companies may be asked to engage in appropriate due diligence tailored to their proposition.

From June 2017 up to three winners of the CGP process will join the Pfizer Healthcare Hub: London as collaborative partners.

Unsuccessful applicants could be contacted to inform them of any alternative opportunities that may meet their needs.  

What if I am involved in another accelerator programme?

You are free to be part of any other accelerator programme and talk to any other potential partners to pursue any exit options with other companies.

Will you provide finance for my business?

The competitive grant offers up to £$70,000 to the selected collaborators. You can apply for funding for whatever you feel will have the greatest impact on achieving your goals. You may be able to access other Pfizer grants and competitions as a hub collaborator during the programme.

When will the programme begin and what is the duration?

The programme will begin in June 2017 and the duration will be up to twelve months. If your growth strategy is to expand to other markets this year you may choose a shorter collaboration period in the UK with support to engage with one of our other global hubs or programmes.

Will the programme be extended beyond twelve months?

This decision will be agreed by both parties at the end of the programme.

What can we expect from the programme?

A personalised programme of mentoring, consulting and support for marketing and collaborating as well as access to Pfizer’s know-how and support to work with those beyond Pfizer who can help you have the biggest impact. As part of Pfizer UK’s Customer Operations team, a dedicated hub team including the hub manger and a network of six scouts are supported by Pfizer’s global Director of Worldwide Innovation, UK and European colleagues to get the most from the scheme.

What happens after the programme ends?

This will depend on the individual businesses, but may include extended partnership and invitation for further collaboration opportunities.

Who will this programme benefit?

Applicants with a digital innovation, that can show how they could improve the lives of patients directly, or indirectly by addressing the needs of the NHS or healthcare professionals, may benefit.

The Healthcare Hub is designed to support those companies who are ready to scale, to reach more patients or providers. If you are struggling to find the agents of change in your local healthcare network, if you are looking for support to understand your local market or new markets, advice on growing your team, support developing plans for investors or reaching patient groups then working with the hub could help. 

I’m still not sure if I qualify?

Have a look at our Legal section for more details, after that, feel free to apply anyway. We can clarify if you meet the eligibility criteria to enter but will not provide specific feedback on your application beyond that until after the competition closes.